peptide stability FAQ

Discard the vial. Selank amidate undergoes hydrolytic peptide bond cleavage at room temperature (20–25°C) at roughly five times the rate observed at 4°C. An eight-hour overnight excursion can cause 10–15% potency loss. The degradation products (truncated peptide fragments) remain in solution and are invisible to visual inspection, which means you cannot verify remaining potency without HPLC analysis. Using a partially degraded solution introduces uncontrolled variability into your protocol that makes data interpretation unreliable.

You can't extend the 28-day window without accepting potency loss and contamination risk. The bacteriostatic agent (0.9% benzyl alcohol) loses antimicrobial efficacy after four weeks, and peptide hydrolysis continues regardless of bacterial presence. If your research protocol requires longer timelines, reconstitute smaller volumes in separate vials and stagger reconstitution dates. For example, reconstitute 1mg every two weeks rather than 3mg at once. Alternatively, explore freeze-dried aliquoting: some researchers divide lyophilised powder into smaller vials before adding water, allowing precise single-use reconstitution. This requires sterile technique and typically isn't practical outside professional lab settings.

Check for condensation inside the vials and on the packaging. If the lyophilised peptides remained below 0°C throughout the outage, they're likely still viable. Lyophilised compounds tolerate brief temperature increases as long as they don't reach the melting point of residual moisture. If condensation is present, the vials warmed above freezing, and water re-entered the system. Contact the supplier to discuss replacement or potency testing. For reconstituted vials stored in the refrigerator during a power outage, check the internal fridge temperature. If it stayed below 10°C, use the peptides within 7 days instead of the full 28-day window. If the temperature exceeded 10°C for more than 2 hours, discard them.

You've lost some potency, but the peptide isn't necessarily ruined. If the excursion was brief (under 8 hours) and didn't exceed 12°C, you can continue using the vial with the understanding that its effective concentration is now lower than labeled. For quantitative work, consider this vial compromised. For exploratory or preliminary studies, it's still usable. The exact activity loss depends on how long the temperature stayed above 8°C. Peptides degrade exponentially faster as temperature rises.

Lyophilised LL-37 tolerates short-term ambient exposure (up to 7 days at 20–25°C) if the vial remained sealed and desiccated. Examine the desiccant packet: if it's saturated (colour change from blue to pink for silica gel), moisture infiltration occurred and the peptide may be partially degraded. If the desiccant is still active, the peptide is likely stable. Transfer to −20°C storage immediately upon receipt.

Check the freezer's temperature log if available. Most research-grade freezers record min/max temperatures. If the temperature rose above −10°C for more than 2 hours, assume 5–10% potency loss for lyophilized peptides and 15–25% loss for reconstituted aliquots. Peptides don't visually change after temperature excursions, so you can't rely on appearance. If the excursion was brief (under 1 hour above −10°C), potency loss is likely under 5%. For critical experiments, order fresh peptide rather than risk inconsistent results.

You can't. Not reliably. Reconstituted peptide solutions degrade in aqueous buffer regardless of refrigeration temperature. After 28 days at 2–8°C, expect 10–15% potency loss; after 60 days, expect 30–40% loss. If your research protocol requires peptide availability over several months, store the compound as lyophilised powder and reconstitute fresh 5–10mg aliquots every four weeks. This approach maintains consistent potency across your study timeline and eliminates batch-to-batch variability caused by progressive degradation in solution.

This range is acceptable for lyophilized Snap-8 storage as long as fluctuations are infrequent and brief (less than 2 hours per week). Peptides tolerate minor temperature variation within the frozen range without significant degradation. The critical failure point is crossing 0°C. Any thaw event, even partial, initiates moisture absorption and peptide bond cleavage. Verify your freezer stays below −10°C at all times with an independent thermometer, and avoid storing peptides in auto-defrost freezers that cycle above 0°C during defrost phases.

Discard the vial immediately. Snap-8 undergoes measurable degradation after just 6–8 hours at room temperature (20–25°C) through peptide hydrolysis and oxidation. Even if the solution looks clear and unchanged, potency has dropped by 20–40%. Continuing to use it introduces unacceptable variability into research results. Temperature excursions above 8°C denature the peptide backbone irreversibly, and no visual inspection or home test can confirm remaining potency.

Discard it immediately. Cloudiness indicates either microbial contamination (if bacteriostatic water was compromised) or peptide aggregation due to improper storage pH or temperature. Neither is salvageable. Selank amidate solutions should remain crystal clear throughout the 28-day window. Any visible change (cloudiness, colour shift, particulates) is a hard stop. Do not attempt to filter or clarify the solution; aggregated peptides have altered pharmacokinetics and cannot be restored to native structure.

Use a portable medical cooler designed for peptide transport. Models like the FRIO wallet use evaporative cooling and maintain 2–8°C for 36–48 hours without ice or electricity. For lyophilized powder, pack the vial with gel ice packs (not loose ice, which introduces moisture) in an insulated container. Monitor temperature with a digital thermometer throughout transit. A single 6-hour excursion above 8°C for reconstituted DSIP can cause partial denaturation.

Use a medical-grade insulin cooler designed to maintain 2–8°C for 24–48 hours without ice or electricity. Products like the FRIO wallet use evaporative cooling and require only a one-time water activation to stay cold for up to two days. Place reconstituted vials inside the cooler with a small adhesive thermometer to monitor actual temperature during transit. Never pack peptides in checked luggage. Temperature in aircraft cargo holds can drop below freezing at altitude, which introduces freeze-thaw damage. Carry peptides in your cabin bag and store the cooler under the seat in front of you, not in the overhead bin where temperature fluctuates.

Do not use it. Freezing a reconstituted peptide solution causes ice crystal formation that physically disrupts peptide tertiary structure. The spatial folding that determines biological activity. When thawed, the solution may appear clear, but the peptide's functional shape has been irreversibly altered. This is why reconstituted peptides must never be stored in a freezer, even short-term.

Discard it immediately. Cloudiness indicates either bacterial contamination or peptide aggregation (clumping of peptide molecules), both of which render the solution unusable. Properly reconstituted DSIP should be clear and colourless. Aggregation occurs when peptides denature and their hydrophobic regions clump together. A sign that storage conditions failed.

Discard the vial. Freezing reconstituted Adamax causes ice crystal formation that mechanically shears the peptide backbone and disrupts copper coordination geometry. Even if you thaw it gently at 4°C, the damage is irreversible. The solution may look clear and homogeneous post-thaw, but the copper-peptide bond has been compromised. Freeze/thaw damage isn't something you can test for without sending a sample for mass spectrometry analysis. Which costs more than replacing the vial. Don't risk experimental inconsistency trying to salvage a frozen sample.

Discard the vial immediately. Freezing aqueous peptide solutions forms ice crystals that physically shear peptide bonds and disrupt tertiary structure through mechanical stress. Once thawed, the solution may appear normal but SS-31's mitochondrial-targeting function will be severely compromised. Research from Caltech's peptide chemistry lab demonstrated that frozen-thawed aromatic peptides lose 60–85% binding affinity to target membranes even when concentration remains unchanged. There is no salvage protocol. Freezing reconstituted solutions is a terminal failure mode.

Discard it. Reconstituted peptide solution stored at room temperature for 8+ hours experiences significant structural degradation. Studies on similar D-amino acid peptides show 30–50% potency loss within 24 hours at 22°C. The peptide may still appear clear and unchanged, but bioactivity drops below therapeutic threshold. Attempting to salvage it by refrigerating after prolonged ambient exposure doesn't reverse the damage. Thermal denaturation is permanent. If the exposure was under four hours and the ambient temperature stayed below 18°C, you might retain partial activity, but there's no home test to verify potency. The financial cost of discarding one vial is lower than the research cost of using compromised peptide that produces unreliable results.

If unreconstituted lyophilised peptide was stored at 20–25°C for 48 hours, it has likely lost 5–10% potency but remains usable for most research protocols. Refrigerate or freeze it immediately and reconstitute within the next 8–12 weeks rather than storing it for months. The real risk is cumulative. If it sat at room temperature during shipping, then again at your facility, then experienced a power outage, you're stacking degradation events. If the vial seal was intact and the powder still appears dry and white (not clumped or discolored), proceed with reconstitution but treat the batch as lower-priority stock.

You can't. Not reliably. The 28-day window reflects the combined stability limits of bacteriostatic water's antimicrobial activity and the peptide's chemical integrity at 2–8°C. Beyond four weeks, bacterial contamination risk increases and copper dissociation accelerates regardless of how carefully you've maintained temperature. If your protocol requires a longer experimental timeline, purchase multiple smaller vials and reconstitute them sequentially rather than trying to extend a single vial's lifespan. Consistency across timepoints matters more than convenience.

Discard it. A reconstituted peptide vial left at room temperature (20–25°C) for 8+ hours has undergone sufficient thermal degradation that bioactivity is unpredictable. Peptide bonds are susceptible to hydrolysis at elevated temperatures, and the process accelerates exponentially above 8°C. You cannot reverse this damage by refrigerating the vial afterward. The degradation already occurred. Using a thermally compromised peptide wastes research time and introduces uncontrolled variables. If you're uncertain about the exposure duration, err on the side of discarding it.